Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new Oxford Sparks animation travels inside our body, shrinking down to a cellular level, to see how amazing our immune system really is. The role of the immune system is to protect us against disease or invading threats, such as viruses, bacteria and parasites. But how does it do that?

The role of the immune system is to protect us against disease or invading threats, such as viruses, bacteria and parasites. But how does it do that?

When looking for new treatments for human disease, one possible strategy is to use observations made in the clinic and work back to the cellular causes. In the Davis and Cornall labs, we follow the opposite strategy - we  seek new treatments for human disease by first trying to understand how healthy cells function, focusing on the processes most likely to impact on disease.

As our video “The immune system - the battle within” shows, there is no process more interesting to investigate than the immune system (or at least we think so!). The immune system is the defence mechanism within our bodies - it normally protects us from foreign pathogens and other threats such as cancer but it is also the root cause of many debilitating diseases, such as diabetes and rheumatoid arthritis.

Watch the Oxford Sparks animation to find out more (Oxford Sparks website)

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.